| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.20 | $66.02 (0%) | 🛒 Add to cart |
| 60 | $1.78 | $132.04 $107.03 (19%) | 🛒 Add to cart |
| 90 | $1.63 | $198.06 $147.04 (26%) | 🛒 Add to cart |
| 120 | $1.57 | $264.08 $188.06 (29%) | 🛒 Add to cart |
| 180 | $1.49 | $396.12 $269.08 (32%) | 🛒 Add to cart |
| 270 | $1.44
Best per pill | $594.18 $390.12 (34%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
rosuvastatin
Rosuvastatin represents one of the most potent synthetic statins available in clinical practice, specifically developed to address dyslipidemia and reduce cardiovascular risk through robust LDL-cholesterol lowering. As a selective, competitive HMG-CoA reductase inhibitor, it occupies a critical position in both primary and secondary prevention strategies for atherosclerotic cardiovascular disease. What’s fascinating—and often misunderstood—is how its unique pharmacokinetic profile allows for once-daily dosing with minimal drug interactions compared to earlier statins, though we’ve learned through hard experience that genetic polymorphisms in SLCO1B1 can dramatically alter patient response.
atorlip 20
Atorlip 20 represents the latest evolution in targeted lipid management, combining 20mg of atorvastatin with a phospholipid complex delivery system that significantly enhances bioavailability compared to conventional formulations. Having worked with lipid disorders for over two decades, I’ve seen countless patients struggle with statin intolerance and inadequate response—until we started incorporating this formulation into our clinical protocols about three years ago. Atorlip 20: Advanced Lipid Management with Enhanced Bioavailability - Evidence-Based Review 1.
biaxin
Biaxin, known generically as clarithromycin, is a macrolide antibiotic with a broad spectrum of activity against many Gram-positive and Gram-negative bacteria, atypical pathogens, and some mycobacteria. It’s not a dietary supplement or medical device but a prescription medication primarily used to treat respiratory tract infections, skin and soft tissue infections, and Helicobacter pylori-associated peptic ulcer disease. The drug works by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit.
Crestor: Potent LDL Cholesterol Reduction for Cardiovascular Risk Management - Evidence-Based Review
Product Description Crestor, known generically as rosuvastatin calcium, is a synthetic lipid-lowering agent belonging to the statin class of medications. Marketed as a prescription pharmaceutical rather than a dietary supplement or medical device, it functions as a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. Available in tablet formulations ranging from 5mg to 40mg, Crestor represents one of the most potent statins available for managing dyslipidemia.
Isoptin: Calcium Channel Blockade for Cardiovascular Conditions - Evidence-Based Review
Isoptin, known generically as verapamil hydrochloride, represents one of the foundational calcium channel blockers in cardiovascular therapeutics. Initially developed in the 1960s by Knoll AG, this phenylalkylamine derivative has maintained clinical relevance for decades due to its unique electrophysiological properties and vascular effects. Unlike dihydropyridine calcium channel blockers that predominantly affect vascular smooth muscle, Isoptin exhibits significant activity on both cardiac myocytes and vascular tissue, creating a distinct therapeutic profile that continues to challenge newer antiarrhythmic and antihypertensive agents.
kaletra
Kaletra represents one of the most significant advances in HIV treatment over the past two decades. As a fixed-dose combination of lopinavir and ritonavir, this antiretroviral medication fundamentally changed how we manage HIV-1 infection, particularly in treatment-naïve patients and those with resistance concerns. What many don’t realize is that the development team nearly abandoned the project twice due to formulation challenges - the original tablet required refrigeration and had significant food effect issues that made adherence difficult for our most vulnerable patients.
lasuna
Lasuna, derived from Allium sativum or aged garlic extract, represents one of the more interesting developments in cardiovascular nutraceuticals. Unlike raw garlic supplements which cause gastrointestinal distress and have unstable active compounds, this specific formulation undergoes a 20-month aging process that converts harsh alliin into stable, bioavailable S-allyl cysteine and other organosulfur compounds. What’s fascinating clinically isn’t just the cholesterol numbers - it’s the endothelial protection that makes this relevant for patients who can’t tolerate statins or need adjunct therapy.
Pravachol: Comprehensive Cholesterol Management and Cardiovascular Risk Reduction - Evidence-Based Review
Pravastatin sodium, the active pharmaceutical ingredient in Pravachol, represents one of the earliest and most extensively studied HMG-CoA reductase inhibitors in clinical practice. Originally derived from the fungus Nocardia autotrophica, this hydrophilic statin has demonstrated a robust safety and efficacy profile across decades of use in cardiovascular risk reduction. Unlike newer synthetic statins, pravastatin’s natural origin and unique pharmacokinetic properties continue to make it relevant in contemporary lipid management strategies, particularly for patients experiencing adverse effects with more potent alternatives.
sporanox
Sporanox, known generically as itraconazole, is a systemic antifungal medication belonging to the triazole class. It’s formulated as oral capsules and an oral solution, with the capsules requiring gastric acidity for optimal absorption. This agent has been a cornerstone in mycology for decades, particularly for deep-seated fungal infections where other antifungals fall short. Its broad-spectrum activity covers dermatophytes, yeasts, and molds, making it indispensable for conditions like onychomycosis, blastomycosis, and aspergillosis.